Synlogic Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
SYBX Nasdaq 8731 https://www.synlogictx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Synlogic Inc

Synlogic Reminds Stockholders of 2023 Annual General Meeting Details - Jun 8th, 2023 10:45 am
Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria - Jun 5th, 2023 10:45 am
Synlogic Announces Data Presentations at the 2023 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference - May 24th, 2023 10:35 am
Synlogic to Present at the Jefferies Global Healthcare Conference - May 23rd, 2023 10:50 am
Synlogic First Quarter 2023 Earnings: Beats Expectations - May 13th, 2023 12:21 pm
3 Penny Stocks That Could Turn $1,000 into $10,000 in a Year - May 11th, 2023 4:38 pm
Synlogic, Inc. (SYBX) Reports Q1 Loss, Lags Revenue Estimates - May 11th, 2023 12:05 pm
Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update - May 11th, 2023 10:50 am
Sidoti's Micro-Cap Virtual May Conference - May 9th, 2023 11:15 am
Synlogic Receives Orphan Drug Designation from FDA for SYNB1934 for Treatment of Phenylketonuria - May 9th, 2023 10:50 am
Analysts Estimate Synlogic, Inc. (SYBX) to Report a Decline in Earnings: What to Look Out for - May 4th, 2023 2:00 pm
3 Megatrend Stocks to Buy for 10x Potential Returns - Apr 28th, 2023 9:12 pm
Synlogic, Inc. (SYBX) Reports Q4 Loss, Misses Revenue Estimates - Mar 29th, 2023 11:55 am
Synlogic Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates - Mar 29th, 2023 10:40 am
Synlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1934 for the Treatment of Phenylketonuria - Mar 28th, 2023 10:52 am
Synlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting - Mar 20th, 2023 10:55 am
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing - Mar 10th, 2023 1:35 pm
Synlogic to Present at the Oppenheimer 33rd Annual Healthcare Conference - Mar 8th, 2023 12:00 pm
Life Sciences Virtual Investor Forum Agenda Announced for March 9th - Mar 7th, 2023 1:35 pm
Synlogic To Present Three Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting - Mar 7th, 2023 11:57 am